Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Progenics Pharmaceuticals, Inc
Department
Type
DUNS #
City
State
Country
Zip Code
Klapper, Yvonne; Hamad, Osama A; Teramura, Yuji et al. (2014) Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles. Biomaterials 35:3688-96
Dey, Antu K; David, Kathryn B; Lu, Min et al. (2009) Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins. Virology 385:275-81
Banerjee, Kaustuv; Andjelic, Sofija; Klasse, Per Johan et al. (2009) Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo. Virology 389:108-21
Kang, Yun Kenneth; Andjelic, Sofija; Binley, James M et al. (2009) Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine 27:5120-32
Dey, Antu K; David, Kathryn B; Klasse, Per J et al. (2007) Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1. Virology 360:199-208
Beddows, Simon; Franti, Michael; Dey, Antu K et al. (2007) A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120. Virology 360:329-40
Iyer, Sai Prasad N; Franti, Michael; Krauchuk, Ammie A et al. (2007) Purified, proteolytically mature HIV type 1 SOSIP gp140 envelope trimers. AIDS Res Hum Retroviruses 23:817-28
Herrera, Carolina; Klasse, Per Johan; Kibler, Christopher W et al. (2006) Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex. Virology 351:121-32
Beddows, Simon; Kirschner, Marc; Campbell-Gardener, Lila et al. (2006) Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A. AIDS Res Hum Retroviruses 22:569-79
Kirschner, Marc; Monrose, Val; Paluch, Maciej et al. (2006) The production of cleaved, trimeric human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein vaccine antigens and infectious pseudoviruses using linear polyethylenimine as a transfection reagent. Protein Expr Purif 48:61-8

Showing the most recent 10 out of 13 publications